Segment information (Tables)

3 Months Ended

Mar. 27, 2016

The following tables present the Company’s segment results for the three months ended March 27, 2016 and March 29, 2015:



	Three Months Ended
	March 27, 2016		March 29, 2015
	(Dollars in thousands)
Revenue
Vascular North America	$	81,588	$	80,766
Anesthesia North America	45,957		45,449
Surgical North America	38,941		38,059
EMEA	122,095		129,282
Asia	49,156		48,529
OEM	33,977		34,715
All other	53,179		52,630
Consolidated net revenues	$	424,893	$	429,430



	Three Months Ended
	March 27, 2016			March 29, 2015
	(Dollars in thousands)
Operating profit
Vascular North America	$	19,656		$	15,750
Anesthesia North America	12,177			9,960
Surgical North America	13,256			12,327
EMEA	21,043			26,335
Asia	13,008			8,146
OEM	5,189			8,043
All other	5,743			3,093
Total segment operating profit (1)	90,072			83,654
Unallocated expenses (2)	(22,575		)	(18,046		)
Income from continuing operations before interest and taxes	$	67,497		$	65,608

(1)

Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.


(2)	Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.